Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 14;14(2):202-217.
doi: 10.1093/phe/phab017. eCollection 2021 Jul.

Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population

Affiliations

Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population

Lisa Dive et al. Public Health Ethics. .

Abstract

Reproductive genetic carrier screening (RCS) is increasingly being offered more widely, including to people with no family history or otherwise elevated chance of having a baby with a genetic condition. There are valid reasons to reject a prevention-focused public health ethics approach to such screening programs. Rejecting the prevention paradigm in this context has led to an emphasis on more individually-focused values of freedom of choice and fostering reproductive autonomy in RCS. We argue, however, that population-wide RCS has sufficient features in common with other public health screening programs that it becomes important also to attend to its public health implications. Not doing so constitutes a failure to address the social conditions that significantly affect people's capacity to exercise their reproductive autonomy. We discuss how a public health ethics approach to RCS is broader in focus than prevention. We also show that additional values inherent to ethical public health-such as equity and solidarity-are essential to underpin and inform the aims and implementation of reproductive carrier screening programs.

PubMed Disclaimer

References

    1. Andermann A., Blancquaert I., Beauchamp S., Costea I. (2011). Guiding Policy Decisions for Genetic Screening: Developing a Systematic and Transparent Approach. Public Health Genomics, 14, 9–16. - PubMed
    1. Andermann A., Blancquaert I., Beauchamp S., Déry V. (2008). Revisiting Wilson and Jungner in the Genomic Age: A Review of Screening Criteria over the past 40 Years. Bulletin of the World Health Organization, 86, 317–320. - PMC - PubMed
    1. Andermann A., Blancquaert I., Déry V. (2010). Genetic Screening: A Conceptual Framework for Programmes and Policy-Making. Journal of Health Services Research & Policy, 15, 90–97. - PubMed
    1. Asch A. (1999). Prenatal Diagnosis and Selective Abortion: A Challenge to Practice and Policy. American Journal of Public Health, 89, 1649–1657. - PMC - PubMed
    1. Badoer C., Marangoni M., Grenet M.-L., Smits G. (2020). Development of an Expanded Carrier Screening Program in Belgium. Poster presented at the annual meeting of the Belgian Society for Human Genetics, March 2020.